Goal: To complete preliminary tests of the first pharmacological approach to treat uveal melanoma (UM) in tumor samples and animals and ultimately determine if these compounds could lead towards a first-in-class, targeted treatment for UM patients.
Principal Investigator: Jieya Shao, PhD

Optimizing Fall-risk Prediction in Older Adults with Cancer
Goal: To better understand the risk factors associated with falls in older adults with cancer and ultimately, to create a tailored fall-prevention intervention that can be tested in a clinical trial.
Principal Investigator: Tanya Wildes, MD
DNA Damage Mediated Checkpoints in Early B Cell Development
Goal: To advance our understanding of the development of pediatric leukemia and identify new treatments by studying a newly identified cellular signaling pathway that can play a role in leukemic cell growth and survival.
Principal Investigator: Jeffrey Bednarski, MD, PhD
Mechanism and Inhibition of PALB2 and BRCA2 Proteins
Goal: To better understand how two tumor suppressor proteins are involved in cancer and the development of resistance to drugs used in cancer treatment, and to find inhibitors of these proteins that could be used to improve anticancer therapy or develop alternative treatments in the future.
Principal Investigator: Sergey Korolev, PhD
SITEMAN CANCER CENTER
A Genetic Model of Perineural Invasion
Goal: To discover the molecular causes of cancer metastasis along nerves (perineural invasion) and better understand the molecular basis of this aggressive yet poorly understood form of metastasis.
Principal Investigators: James Skeath, PhD
Fatty Liver Promotes Hepatic Breast Cancer Metastasis
Goal: To better understand the mechanisms by which fatty liver disease-a reversible and preventable disease-promotes breast cancer metastasis to the liver.
Principal Investigator: Steven Teitelbaum, MD
Nonsense-mediated mRNA Decay in DNA Damage Response
Goal: To better understand the effects DNA damage generated by radiation and chemotherapy has on the healthy cells surrounding the tumor in order to develop new therapeutic strategies that will ultimately lessen side effects and cancer relapses.
Principal Investigator: Zhongsheng You, PhD
RNA as a Target of Alkylation Chemotherapy in Cancer
Goal: To better understand the importance of chemotherapy-induced RNA damage of cells which will impact our understanding of how tumors respond to chemotherapy and ultimately may lead to new targets for chemosensitization.
Principal Investigator: Nima Mosammaparast, MD, PhD
Optimizing Decision Making about Breast Reconstruction after Mastectomy: A Patient-Centered Approach
Goal: To develop a clinical decision support tool that will enable physicians and patients to make high quality breast reconstruction decisions, ultimately improving cancer survivorship for women with breast cancer.
Principal Investigator: Terence Myckatyn, MD
Evaluating Cognitive Function and Functional Connectivity in Breast Cancer Survivors Who Received Chemotherapy
Goal: To better understand the basis of chemotherapy-related cognitive impairment (CRCI) in breast cancer patients to ultimately improve the survivorship experience.
Principal Investigator: Jay Piccirillo, MD
Siteman Cancer Center Breast Cancer SPORE
Goal: To create a Breast Specialized Program of Research Excellence (SPORE) program focused on tumor immunology, oncologic imaging, surgical oncology and breast cancer prevention that will enable researchers to quickly translate basic science discoveries to clinical uses for patients with breast cancer.
Principal Investigator: William Gillanders, MD
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It takes world-class research to create a world without cancer. Thank you for supporting Pedal the Cause and accelerating cancer research.
A full description of Pedal the Cause-funded research projects are available on our website.
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MRI-guided Laser Heat Ablation to Induce Blood Brain Barrier Breakdown in Pediatric Brain Tumors
Goal: Researcher take on one of the biggest obstacles to treating pediatric brain tumors: the blood-brain barrier, which keeps chemotherapy drugs from penetrating the brain.
Principal Investigator: Karen Gauvain, MD, MSPH and David Limbrick, MD, PhD
Sex-specific Super Enhancer Activity in Glioblastoma
Goal: To explore the observation that females are less likely than males to develop glioblastoma (the most devastating form of brain cancer) and when they do, they have better outcomes.
Principal Investigator: Rob Mitra, PhD and Joshua Rubin, MD, PhD
Developing a Novel Reprogramming Strategy for Pediatric Brain Tumor Treatment
